← Back to Search

POTS for Postural Orthostatic Tachycardia Syndrome

N/A
Recruiting
Led By Steven Vernino, MD PhD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.

Eligible Conditions
  • Postural Orthostatic Tachycardia Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Natural history
Phenotyping POTS

Trial Design

2Treatment groups
Experimental Treatment
Group I: POTSExperimental Treatment1 Intervention
Patients meeting clinical criteria for postural orthostatic tachycardia syndrome who meet other criteria for inclusion.
Group II: Healthy matched controlsExperimental Treatment1 Intervention
Age and sex matched controls

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,176 Total Patients Enrolled
11 Trials studying Postural Orthostatic Tachycardia Syndrome
490 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
University of Texas Southwestern Medical CenterLead Sponsor
1,052 Previous Clinical Trials
1,054,625 Total Patients Enrolled
1 Trials studying Postural Orthostatic Tachycardia Syndrome
30 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Steven Vernino, MD PhDPrincipal InvestigatorUT Southwestern Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
Steven Vernino MD PhD 2024. "Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06292104.
All > Dallas > Fort Worth
~233 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top